Viewing Study NCT05651893


Ignite Creation Date: 2025-12-25 @ 1:23 AM
Ignite Modification Date: 2025-12-27 @ 7:30 AM
Study NCT ID: NCT05651893
Status: UNKNOWN
Last Update Posted: 2023-04-06
First Post: 2022-12-07
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Efficacy of Second Forward-view Examination of Left Colon for Adenoma Detection During Colonoscopy
Sponsor: Changhai Hospital
Organization:

Study Overview

Official Title: Efficacy of Second Forward-view Examination of Left Colon for Adenoma Detection During Colonoscopy: a Multicenter, Prospective, Randomized Controlled Trial
Status: UNKNOWN
Status Verified Date: 2023-04
Last Known Status: RECRUITING
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The incidence of colorectal cancer in China is increasing year by year. Studies have shown that colorectal cancer is more common in the left colon,especially in the China. Our previous study also showed a higher rate of missed adenoma in the left colon than the right colon during colonoscopy. Additionally, prolonging withdrawal time could only improve the ADR of right colon, but had limited effect on the ADR of left colon in our previous research. Our aim is to evaluate the effect of a second forward view examination of the left colon on the detection of adenoma detection during colonoscopy.
Detailed Description: None

Study Oversight

Has Oversight DMC: True
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: